MEDIUM confidence: 100% data completeness, but the composite (51) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
| Metric (USD) | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $33.5B— | $34.7B+3.7% | $28.9B-16.8% | $29.8B+3.2% | $36.0B+20.6% |
| EPS (dil.) | $6.90— | $6.02-12.8% | $11.17+85.5% | $5.92-47.0% | $9.75+64.7% |
| Free Cash Flow | $266M— | $704M+164.7% | $932M+32.4% | $1.2B+25.8% | $1.4B+17.2% |
| Gross Margin | 7.9% | 8.3%+0.4pp | 9.3%+1.0pp | 8.9%-0.4pp | 9.2%+0.3pp |
| Operating Margin | 4.2% | 4.4%+0.3pp | 7.0%+2.5pp | 4.0%-3.0pp | 4.7%+0.8pp |
| Net Margin | 3.0% | 2.4%-0.6pp | 4.8%+2.4pp | 2.2%-2.6pp | 2.9%+0.7pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth below the analyst consensus of 18.5%/yr (revenue basis).
Base free cash flow $1.2B (avg FY2024–FY2026; latest year $1.4B) · equity value $27.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
Net insider -$277K over 180 days (0 open-market buys, 6 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Buy-rated share 80% → 90% over ~3 months (+10pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Sep 2026 | $4.07 | $4.40 | +8.1% |
| Jun 2026 | $3.10 | $3.16 | +1.9% |
| Mar 2026 | $2.51 | $2.69 | +7.2% |
| Dec 2025 | $2.70 | $2.85 | +5.6% |
| Sep 2025 | $2.92 | $3.29 | +12.7% |
| Jun 2025 | $2.31 | $2.55 | +10.4% |
| Mar 2025 | $1.83 | $1.94 | +6.0% |
| Dec 2024 | $1.88 | $2.00 | +6.4% |
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Jabil's QScore of 51 indicates a neutral outlook, driven by a mix of factors. The stock scores high on risk, with a relatively low beta of 1.3, but exhibits strong profitability, with an ROE near 74%. However, its value score is tempered by a P/E of 27.5 and P/B of 17.6, indicating a premium valuation, while momentum is a concern due to a -15.1% return over the past three months and a bearish moving average trend. The long-term and short-term scores are relatively aligned, suggesting a consistent view of the stock's prospects.